In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...

Move comes 2 years after controversial exit of brand-name product ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

New research from National Jewish Health suggests that long-acting beta-agonists (LABAs), commonly used in combination asthma ...

To inform clinicians on the best biologic agent for different populations of adults with severe asthma, 12 experts collaborated on a new clinical practice guideline published in CHEST, according to a ...

Please provide your email address to receive an email when new articles are posted on . Early exposure to high levels of an air pollutant and home dampness each increased the risk for childhood asthma ...

Real-world data from 2016 to 2025 highlight the changing landscape of biologic use and the growing preference for tezepelumab in asthma.

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

LEHIGH VALLEY, Pa. - A new report says the Lehigh Valley still isn't a very welcoming place for those living with asthma. According to the nonprofit Asthma and Allergy Foundation of America (AAFA), ...

Bedfont ® Scientific Limited, an innovative med-tech company specializing in medical breath analysis devices, welcomes the new study at University Hospital Southampton exploring whether enhanced ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

A retrospective cohort study of 210,000 pediatric patients showed ICS therapy did not elevate the risk for pediatric fractures.